Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 106Recruiting 94Not yet recruiting 30Unknown 29Active not recruiting 17Terminated 15Withdrawn 7Enrolling by invitation 7Suspended 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

Oxaloacetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Withdrawn × Myasthenia Gravis × Clear all
NCT04965987 2025-07-11

Oxaloacetate in Myasthenia Gravis

University of Kansas Medical Center

Phase 1 Withdrawn

Myasthenia Gravis

NCT06419166 2025-06-27

gMG

Zhejiang University

Phase EARLY_PHASE1 Withdrawn

Myasthenia Gravis

NCT04224506 2025-06-05

A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis

ProgenaBiome

Withdrawn

Myasthenia Gravis

NCT04541875 2022-05-12

Medication Adherence and Non-adherence in Adults With Rare Disease

Xperiome

Withdrawn
Classical hematology

Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Hemophilia A, Myasthenia Gravis, Rare Diseases, Idiopathic Pulmonary Fibrosis

NCT04982289 2022-02-11

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

Alexion Pharmaceuticals, Inc.

Phase 2 Withdrawn

Myasthenia Gravis

NCT03900585 2021-03-10

Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients

Rigshospitalet, Denmark

Phase NA Withdrawn

Myasthenia Gravis

NCT03165435 2018-05-30

A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

CuraVac

Phase 2/3 Withdrawn

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡